Table 5.
Number of deaths | Hazard ratio (95%CI) | ||
---|---|---|---|
Aspirin | Clopidogrel + aspirin + | ||
All participants | |||
All deaths | 78 | 113 | 1.5 (1.1, 2.0) |
Vascular* | 25 | 45 | 1.9 (1.1, 3.0) |
Non-vascular | 31 | 39 | |
Uncertain cause | 22 | 29 | |
Ischemic heart disease ± stage I/ II hypertension at entry | |||
All deaths | 11 | 30 | 2.9 (1.4, 5.8) |
Vascular* | 4 | 14 | 3.8 (1.2, 12) |
Non-vascular | 4 | 9 | |
Uncertain cause | 3 | 7 | |
Normotensive/pre-hypertensive and no ischemic heart disease at entry | |||
All deaths | 8 | 28 | 3.3 (1.5, 7.3) |
Vascular* | 0 | 11 | >60 (0.51,> 1000) |
Non-vascular | 6 | 9 | |
Uncertain cause | 2 | 8 | |
Stage I/II hypertension and no ischemic heart disease at entry | |||
All deaths | 59 | 55 | 0.98 (0.68, 1.4) |
Vascular* | 21 | 20 | 1.0 (0.54, 1.8) |
Non-vascular | 21 | 21 | |
Uncertain cause | 17 | 14 |
Includes definite and probable vascular deaths (defined in supplementary appendix)